Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 57 (1), 74-82
- https://doi.org/10.1016/0090-1229(90)90023-j
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.The Journal of Experimental Medicine, 1987
- The interleukin 2 receptor. Functional consequences of its bimolecular structure.The Journal of Experimental Medicine, 1987
- Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.The Journal of Experimental Medicine, 1987
- Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.The Journal of Experimental Medicine, 1984
- Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.JCI Insight, 1984
- Spontaneous release of the Leu-2 (T8) molecule from human T cells.The Journal of Experimental Medicine, 1983
- The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody‐Forming B Cell ResponsesImmunological Reviews, 1982